Martin Austin
Directeur Général chez TransformRX GmbH
Profil
Martin Austin is currently the Chairman at Zestagen AG, Director at AlgiPharma APR AS, RSA AG, and Devirex AG, Managing Director & Owner at TransformRX GmbH, and Partner at Ventac Partners GmbH.
He is also a Partner at MarraM Advisors SARL.
In the past, he served as Chairman & Director-Business Development at Guard Therapeutics International AB from 2016 to 2018, Chairman at Preelumina Diagnostics AB, Head-Business Development at Hoffmann-La Roche, Inc., and Principal at Paul Capital Partners LP.
Postes actifs de Martin Austin
| Sociétés | Poste | Début |
|---|---|---|
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Corporate Officer/Principal | 01/09/2010 |
| Zestagen AG | Président | - |
| RSA AG | Directeur/Membre du Conseil | - |
| Devirex AG | Directeur/Membre du Conseil | - |
MarraM Advisors SARL
 MarraM Advisors SARL Investment ManagersFinance MarraM Advisors SARL provides investment advisory services. | Corporate Officer/Principal | - |
| TransformRX GmbH | Directeur Général | - |
| AlgiPharma APR AS | Directeur/Membre du Conseil | - |
Anciens postes connus de Martin Austin
| Sociétés | Poste | Fin |
|---|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Président | 26/11/2018 |
| Preelumina Diagnostics AB | Président | - |
| ░░░░ ░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Health Technology |
| Entreprise privées | 10 |
|---|---|
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Finance |
Ventac Partners GmbH
Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Commercial Services |
| AlgiPharma APR AS | |
| Preelumina Diagnostics AB | |
| Zestagen AG | |
| Devirex AG | |
MarraM Advisors SARL
MarraM Advisors SARL Investment ManagersFinance MarraM Advisors SARL provides investment advisory services. | Finance |
| TransformRX GmbH | |
| RSA AG |
